site stats

Citregen tis and citrelock

WebMay 9, 2024 · The research and patents by Ameer and Yang are the core biomaterial technology used in new implantable medical devices developed by Acuitive Technologies Inc. Citregen, the first thermoset ... WebOct 21, 2024 · Named CITRELOCK (TM), the initial device of Acuitive Technologies' CITREGEN (TM) material is composed of a citrate-based synthetic biomaterial co-invented by Penn State's Jian Yang and ...

Novel bioresorbable, tissue-healing surgical device approved by FDA

WebOct 21, 2024 · Acuitive Technologies received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRELOCK Interference Screw System with CITREGEN material technology, a new generation thermoset bioresorbable synthetic polymer now FDA cleared. The CITRELOCK system is intended to attach tissue during … WebMore About Citregen The CITREFIX Knotless Suture Anchors are designed to be tapped into place and enable the surgeon use of their preferred sutures. Providing versatility, speed, and security, CITREFIX Knotless … inches in 8 ft https://multiagro.org

Stryker Launches New Tendon Fixation Device System - OR …

WebSep 17, 2024 · The Citrelock Tendon Fixation Device System utilizes Citregen’s unique material properties features to ease insertion and secure fixation without damaging the … WebSep 24, 2024 · CITREGEN has unique chemical and mechanical properties for orthopaedic surgical applications that help grafted tissue heal. It contains organic molecules and … WebFeb 11, 2024 · The CITREFIX system is intended to assist the attachment of tissue to bone during orthopedic surgeries such as fixation of ligaments or tendon graft tissue repairs of … inches in 9 cm

Citrefix Acuitive Technologies

Category:The 2024 Society for Biomaterials, Technology Innovation and ...

Tags:Citregen tis and citrelock

Citregen tis and citrelock

The 2024 Society for Biomaterials, Technology Innovation and ...

WebOct 21, 2024 · CITREGEN is the core material technology in the CITRELOCK Interference Screw System, which will be produced and marketed by Acuitive Technologies Inc. The …

Citregen tis and citrelock

Did you know?

WebAcuitive Technologies, Inc., a sublicensee of Ameer’s startup VesselTek Biomedical, plans to commercialize the CITRELOCK TM System in early 2024 alongside an orthopedic distribution partner. Researchers from The Pennsylvania State University, led by CITREGEN co-inventor and former Ameer postdoctoral trainee Jian Yang, PhD, who leads that ... WebInspired by nature, CITREGEN is a paradigm-changing synthetic biomaterial purposefully designed on a molecular level to replicate the intrinsic cellular support network. CITREGEN 's main component, citrate, is historically known as a naturally occurring metabolic molecule but has recently been shown to play important roles in bone anatomy.

WebThe Citregen Tendon Interference Screw (TIS) and Citrelock are intended for soft tissue reattachment, i.e. fixation of ligament and tendon graft tissue in surgeries of the … WebNov 12, 2024 · The FDA recently approved Acuitive Technology’s CITRELOCK Interference Screw System with CITREGEN Materials Technology, a next-generation thermosetting …

WebCITREGEN is the first thermoset biodegradable synthetic polymer ever used in implantable medical devices. CITRELOCK, which received clearance from the US Food and Drug Administration last year, has a compressive strength comparable to cortical bone and maintains structural integrity during the healing phase, while allowing the implant to be ... WebOct 21, 2024 · CITREGEN is the core material technology in the CITRELOCK™ Interference Screw System, which will be produced and marketed by Acuitive …

WebOct 14, 2024 · Citregen contains citrate, calcium, and phosphate molecules that are inherent to the bone anatomy. Material polymer structure that mimics the extracellular …

WebMar 5, 2024 · March 5, 2024 By Danielle Kirsh. Acuitive Technologies this week announced that it received FDA 510 (k) clearance for its Citrespline and Citrelock ligament reconstruction devices. The two systems ... inches in 9mmWebCITREGEN Technology. CITREGEN. Technology. ®. Inspired by nature, CITREGEN is a paradigm-changing synthetic biomaterial purposefully designed on a molecular level to replicate the intrinsic cellular support … inches in 9cmWebDec 13, 2024 · After the successful launch of Citrelock last year, Citrefix is the second product in Stryker’s expanding portfolio using the material, with additional products expected in 2024. Citregen was awarded the 2024 Technology Innovation and Development Award by the Society for Biomaterials earlier this year. incoming meme animationWebSep 22, 2024 · The biomaterial technology, called CITREGEN™, developed by the start-up company Acuitive Technologies, Inc., is featured in Stryker Corporation’s CITRELOCK™, an innovative device that will debut this week at the American Orthopaedic Foot and Ankle Society’s annual meeting in Charlotte, N.C. The CITRELOCK™ Tendon Fixation Device … incoming message has no type attributeWebSep 17, 2024 · Stryker’s Trauma & Extremities division has launched its Citrelock Tendon Fixation Device System. The new system provides surgeons a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, that has unique chemical and mechanical properties for orthopaedic surgical applications. incoming memphis flightsWebSep 17, 2024 · Citregen, in particular, has chemical and mechanical qualities intended for orthopaedic surgical applications. The company is expected to debut the Citrelock Tendon Fixation Device System at the ... inches in a cubic footWebMar 5, 2024 · “The CITRESPLINE/CITRELOCK System is the third innovation from our robust pipeline of CITREGEN based products that is cleared for commercialization in the US.” CITREGEN is a synthetic biomaterial developed on a molecular level to oversee tissue regeneration by replicating the intrinsic cellular biochemical and structural support network. inches in a fathom